Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Non-Current Liabilities: 2024-2025

Historic Other Non-Current Liabilities for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Sep 2025 value amounting to $761,000.

  • Day One Biopharmaceuticals' Other Non-Current Liabilities was N/A to $761,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $761,000, marking a year-over-year change of. This contributed to the annual value of $761,000 for FY2024, which is N/A change from last year.
  • As of Q3 2025, Day One Biopharmaceuticals' Other Non-Current Liabilities stood at $761,000, which was down 0.00% from $761,000 recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Other Non-Current Liabilities registered a high of $761,000 during Q4 2024, and its lowest value of $761,000 during Q4 2024.
  • Its 2-year average for Other Non-Current Liabilities is $761,000, with a median of $761,000 in 2025.